NO920201L - Heksacyklisk forbindelse - Google Patents

Heksacyklisk forbindelse

Info

Publication number
NO920201L
NO920201L NO92920201A NO920201A NO920201L NO 920201 L NO920201 L NO 920201L NO 92920201 A NO92920201 A NO 92920201A NO 920201 A NO920201 A NO 920201A NO 920201 L NO920201 L NO 920201L
Authority
NO
Norway
Prior art keywords
compound
hexacyclic
relationship
antitumour
abundantly
Prior art date
Application number
NO92920201A
Other languages
English (en)
Other versions
NO180448C (no
NO920201D0 (no
NO180448B (no
Inventor
Hirofumi Terasawa
Akio Ejima
Satoru Ohsuki
Koichi Uoto
Original Assignee
Daiichi Seiyaku Co
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co, Yakult Honsha Kk filed Critical Daiichi Seiyaku Co
Publication of NO920201D0 publication Critical patent/NO920201D0/no
Publication of NO920201L publication Critical patent/NO920201L/no
Publication of NO180448B publication Critical patent/NO180448B/no
Publication of NO180448C publication Critical patent/NO180448C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO920201A 1991-01-16 1992-01-15 Heksacyklisk forbindelse NO180448C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1581291 1991-01-16

Publications (4)

Publication Number Publication Date
NO920201D0 NO920201D0 (no) 1992-01-15
NO920201L true NO920201L (no) 1992-07-17
NO180448B NO180448B (no) 1997-01-13
NO180448C NO180448C (no) 1997-04-23

Family

ID=11899258

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920201A NO180448C (no) 1991-01-16 1992-01-15 Heksacyklisk forbindelse

Country Status (15)

Country Link
EP (1) EP0495432B1 (no)
JP (1) JP3008226B2 (no)
KR (1) KR100191193B1 (no)
AT (1) ATE138661T1 (no)
AU (1) AU640549B2 (no)
CA (1) CA2059305C (no)
DE (1) DE69211023T2 (no)
DK (1) DK0495432T3 (no)
ES (1) ES2090366T3 (no)
FI (1) FI103047B (no)
GR (1) GR3020395T3 (no)
HK (1) HK1001561A1 (no)
IE (1) IE920079A1 (no)
NO (1) NO180448C (no)
RU (1) RU2071476C1 (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658920A (en) * 1991-01-16 1997-08-19 Daiichi Pharmaceutical Co., Ltd. Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound
US6407115B1 (en) * 1991-01-16 2002-06-18 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic compound
KR100406020B1 (ko) * 1995-02-22 2004-03-20 다이이찌 세이야꾸 가부시기가이샤 아미노테트라론유도체및그제조방법
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
IN189180B (no) * 1997-07-09 2003-01-04 Chong Kun Dang Corp
AR030207A1 (es) * 2000-04-07 2003-08-13 Daiichi Seiyaku Co Composicion farmaceutica que contiene un derivado de camptotecina y procedimiento de preparacion de la misma
DE60230097D1 (de) 2001-05-08 2009-01-15 Mitsui Chemicals Polyurethanes Verfahren zur herstellung von 1,5-diaminonaphthalinen
BR0214615A (pt) 2001-11-30 2004-09-14 Chugai Pharmaceutical Co Ltd Composto hexacìclico
KR100501439B1 (ko) * 2002-09-27 2005-07-18 현대자동차주식회사 차량 충돌시 연료 누출 방지장치
WO2004073601A2 (en) * 2003-02-21 2004-09-02 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of hexacyclic camptothecin derivatives
CN1964979B (zh) 2004-04-09 2011-07-27 中外制药株式会社 新颖的水溶性前药
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
ITMI20061475A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG172363A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Synthesis of purine nucleosides
WO2010075517A2 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside analogs
CL2009002207A1 (es) 2008-12-23 2011-02-18 Gilead Pharmasset Llc Compuestos derivados de 3-hidroxi-5-(9h-purin-9-il)tetrahidrofuran-2-il, inhibidor de la replicacion de arn viral dependiente de arn; composicion farmaceutica; uso para el tratamiento de hepatitis c.
AP3515A (en) 2010-03-31 2016-01-11 Gilead Pharmasset Llc Nucleoside phosphoramidates
CN115960111A (zh) 2012-10-11 2023-04-14 第一三共株式会社 抗体－药物偶联物
US9872924B2 (en) 2012-10-19 2018-01-23 Daiichi Sankyo Company, Limited Antibody-drug conjugate produced by binding through linker having hydrophilic structure
KR102088169B1 (ko) 2013-12-25 2020-03-12 다이이찌 산쿄 가부시키가이샤 항 trop2 항체-약물 컨쥬게이트
JP5998289B2 (ja) 2014-01-31 2016-09-28 第一三共株式会社 抗ｈｅｒ２抗体−薬物コンジュゲート
JP6612738B2 (ja) 2014-04-10 2019-11-27 第一三共株式会社 抗ｈｅｒ２抗体−薬物コンジュゲート
WO2015155998A1 (en) 2014-04-10 2015-10-15 Daiichi Sankyo Company, Limited Anti-her3 antibody-drug conjugate
JP6787890B2 (ja) 2015-06-29 2020-11-18 第一三共株式会社 抗体−薬物コンジュゲートの選択的製造方法
US20190330368A1 (en) 2016-10-07 2019-10-31 Daiichi Sankyo Company, Limited Therapy for drug-resistant cancer by administration of anti-her2 antibody/drug conjugate
JPWO2018110515A1 (ja) 2016-12-12 2019-10-24 第一三共株式会社 抗体−薬物コンジュゲートと免疫チェックポイント阻害剤の組み合わせ
WO2018135501A1 (ja) 2017-01-17 2018-07-26 第一三共株式会社 抗ｇｐｒ２０抗体及び抗ｇｐｒ２０抗体－薬物コンジュゲート
TWI794230B (zh) 2017-05-15 2023-03-01 日商第一三共股份有限公司 抗ｃｄｈ６抗體及抗ｃｄｈ６抗體-藥物結合物、以及其製造方法
KR20200041993A (ko) 2017-08-31 2020-04-22 다이이찌 산쿄 가부시키가이샤 항체-약물 콘주게이트의 개량 제조 방법
AU2018327170B2 (en) 2017-08-31 2021-03-11 Daiichi Sankyo Company, Limited Novel method for producing antibody-drug conjugate
SG11202010496WA (en) 2018-05-18 2020-12-30 Daiichi Sankyo Co Ltd Anti-muc1 antibody-drug conjugate
CN118221763A (zh) 2019-03-29 2024-06-21 免疫医疗有限公司 化合物及其缀合物
TW202140076A (zh) * 2020-01-22 2021-11-01 英商梅迪繆思有限公司 化合物及其軛合物
MX2022009052A (es) * 2020-01-22 2022-08-15 Medimmune Ltd Compuestos y conjugados de estos.
CN111470998B (zh) * 2020-06-28 2020-09-25 上海皓元生物医药科技有限公司 用于合成喜树碱衍生物的中间体及其制备方法和用途
KR20230118891A (ko) * 2020-12-11 2023-08-14 위겐 바이오메더슨 테크널러지 (상하이) 컴퍼니 리미티드 신규한 캄프토테신 유도체, 이를 포함하는 조성물 및이의 용도
AU2022216696A1 (en) * 2021-02-05 2023-08-17 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Camptothecin compound, preparation method therefor, and application thereof
CN116888123A (zh) * 2021-02-09 2023-10-13 微境生物医药科技(上海)有限公司 用于adc制备的喜树碱衍生物
CN115703712A (zh) * 2021-08-17 2023-02-17 江苏迈威康新药研发有限公司 5,8-二氨基-3,4-二氢-2h-1-萘酮的合成方法以及其中采用的中间体化合物
CN115724758A (zh) * 2021-08-24 2023-03-03 杭州中美华东制药有限公司 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法
WO2023072143A1 (zh) * 2021-10-26 2023-05-04 上海弼领生物技术有限公司 一种喜树碱类衍生物中间体、其制备方法和用途
EP4429709A1 (en) 2021-11-09 2024-09-18 Tubulis GmbH Conjugates comprising a phosphorus (v) and a camptothecin moiety
US11814394B2 (en) 2021-11-16 2023-11-14 Genequantum Healthcare (Suzhou) Co., Ltd. Exatecan derivatives, linker-payloads, and conjugates and thereof
KR20240113514A (ko) 2021-11-30 2024-07-22 다이이찌 산쿄 가부시키가이샤 프로테아제 분해성 마스크 항체
AU2022408887A1 (en) * 2021-12-16 2024-07-18 Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. Camptothecin compound and conjugate thereof
AU2023218678A1 (en) 2022-02-09 2024-08-01 Daiichi Sankyo Company, Limited Environmentally responsive masked antibody and use thereof
WO2024020536A1 (en) * 2022-07-22 2024-01-25 Nj Bio, Inc. Hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells
US20240116945A1 (en) * 2022-09-02 2024-04-11 Merck Sharp & Dohme Llc Exatecan-derived topoisomerase-1 inhibitors pharmaceutical compositions, and uses thereof
US20240190958A1 (en) 2022-10-18 2024-06-13 Tubulis Gmbh Novel antibody drug conjugates with novel napi2b antibodies, therapeutic methods and uses thereof
WO2024083953A1 (en) 2022-10-18 2024-04-25 Tubulis Gmbh Novel anti-tpbg antibody and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof
US20240269313A1 (en) 2022-12-22 2024-08-15 Tubulis Gmbh Conjugates comprising a phosphorus(v) moiety and a drug
WO2024153159A1 (zh) * 2023-01-18 2024-07-25 上海森辉医药有限公司 一种四氢-1-萘胺及其衍生物的制备方法
WO2024158996A2 (en) * 2023-01-25 2024-08-02 Zeno Management, Inc. Immunoconjugates and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives

Also Published As

Publication number Publication date
FI920194A (fi) 1992-07-17
EP0495432A1 (en) 1992-07-22
ES2090366T3 (es) 1996-10-16
GR3020395T3 (en) 1996-09-30
FI920194A0 (fi) 1992-01-16
JPH0559061A (ja) 1993-03-09
CA2059305C (en) 2001-07-31
RU2071476C1 (ru) 1997-01-10
AU1018592A (en) 1992-07-23
NO180448C (no) 1997-04-23
IE920079A1 (en) 1992-07-29
KR100191193B1 (ko) 1999-06-15
ATE138661T1 (de) 1996-06-15
HK1001561A1 (en) 1998-06-26
JP3008226B2 (ja) 2000-02-14
AU640549B2 (en) 1993-08-26
FI103047B1 (fi) 1999-04-15
DK0495432T3 (da) 1996-10-21
EP0495432B1 (en) 1996-05-29
NO920201D0 (no) 1992-01-15
NO180448B (no) 1997-01-13
DE69211023T2 (de) 1997-01-09
KR920014816A (ko) 1992-08-25
CA2059305A1 (en) 1992-07-17
FI103047B (fi) 1999-04-15
DE69211023D1 (de) 1996-07-04

Similar Documents

Publication Publication Date Title
NO920201L (no) Heksacyklisk forbindelse
DK344488A (da) Hexacycliske forbindelser
CA2100258A1 (en) Acridine Derivatives
GR3007919T3 (no)
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
YU69289A (en) Substituted flavonoidic compounds, their salts and process for producing thereof
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
FI884077A (fi) Amidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande kompositioner foer aktivering av gastrisk motorfunktion.
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
DE69810373D1 (de) Pyrrolidin Derivate, Anti-ulcus und Antibakterielle Arzneimittel
ZA91570B (en) A novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament
ATE58129T1 (de) Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung.
EP0357109A3 (en) Platinum-(ii)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action which contains this compound and also shaped preparations with an anti-tumour action
DK0412464T3 (da) Butalactin, en fremgangsmåde til dets fremstilling og dets anvendelse som lægemiddel